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Interleukin-1 receptor 8 (IL-1R8, also known as single 
immunoglobulin IL-1R-related receptor, SIGIRR, or TIR8) is a 
member of the IL-1 receptor (ILR) family with distinct structural 
and functional characteristics, acting as a negative regulator of ILR 
and Toll-like receptor (TLR) downstream signalling pathways and 
inflammation1. Natural killer (NK) cells are innate lymphoid cells 
which mediate resistance against pathogens and contribute to the 
activation and orientation of adaptive immune responses2–4. NK cells 
mediate resistance against haematopoietic neoplasms but are generally 
considered to play a minor role in solid tumour carcinogenesis5–7. Here 
we report that IL-1R8 serves as a checkpoint for NK cell maturation 
and effector function. Its genetic blockade unleashes NK-cell-mediated 
resistance to hepatic carcinogenesis, haematogenous liver and lung 
metastasis, and cytomegalovirus infection.
Several lines of evidence suggest that IL-1R8 interferes with the 
association of TIR module-containing adaptor molecules with signal-
ling receptor complexes of the ILR or TLR family, tuning downstream 
signalling, thus negatively controlling inflammatory and immune 
responses and T helper cell polarization and functions1,8. Moreover, 
IL-1R8 is the co-receptor of IL-1R5/IL-18Rα for IL-37, and is required 
for the anti-inflammatory activity of this human cytokine9. Deregulated 
activation by ILR or TLR ligands in IL-1R8-deficient mice has been 
associated with exacerbated inflammation and immunopathology, 
including selected cancers, or autoimmune diseases10.
IL-1R8 is widely expressed10. However, we found strikingly high 
 levels of IL-1R8 mRNA and protein in human NK cells, compared 
with other circulating leukocytes and monocyte-derived macrophages 
(Fig. 1a and Extended Data Fig. 1a). IL1R8 mRNA levels increased 
 during NK cell maturation11 (Extended Data Fig. 1b) and surface 
 protein expression mirrored transcript levels (Fig. 1b and Extended 
Data Fig. 1c). IL-1R8 expression was detected at a low level in bone 
marrow pluripotent haematopoietic stem cells and NK cell precursors, 
and was selectively upregulated in mature NK cells but not in CD3+ 
lymphocytes (Extended Data Fig. 1d).
Mouse NK cells expressed significantly higher levels of Il1r8 mRNA 
compared with other leukocytes (Fig. 1c) and other ILRs (Extended 
Data Fig. 1e, f). In line with the results obtained in human NK cells, 
the Il1r8 mRNA level increased during the four-stage  developmental 
transition from CD11blowCD27low to CD11bhighCD27low (ref. 12) 
(Fig. 1d and Extended Data Fig. 1g).
To assess the role of IL-1R8 in NK cells, we took advantage of IL-1R8-
deficient mice. Among CD45+ cells, the NK cell frequency and absolute 
numbers were significantly higher in peripheral blood of Il1r8−/− 
 compared with Il1r8+/+ mice, and slightly increased in liver and spleen. 
(Fig. 2a, b). In addition, the frequency of the CD11bhighCD27low and 
KLRG1+ mature subsets were significantly higher in Il1r8−/− mice 
than Il1r8+/+ mice in bone marrow, spleen and blood, indicating a 
more mature phenotype of NK cells13 (Fig. 2c, d and Extended Data 
Fig. 2a, b).
The enhanced NK cell maturation in Il1r8−/− mice occurred already 
at 2 and 3 weeks of age, whereas the frequency of NK precursors was 
similar in Il1r8−/− and Il1r8+/+ bone marrow, indicating that IL-1R8 
regulated early events in NK cell differentiation, but did not affect the 
development of NK cell precursors12 (Extended Data Fig. 2c–e).
We next investigated whether IL-1R8 affected NK cell function. 
The expression of the activating receptors NKG2D, DNAM-1 and 
Ly49H was significantly upregulated in peripheral blood Il1r8−/− NK 
cells (Extended Data Fig. 2f). Interferon-γ (IFNγ ) and granzyme B 
 production and FasL expression were more sustained in IL-1R8-
deficient NK cells upon ex vivo stimulation in the presence of IL-18 
(Fig. 2e–g and Extended Data Fig. 2g). The frequency of IFNγ + NK 
cells was higher in Il1r8−/− total NK cells and in all NK cell subsets. 
Thus, IFNγ  production was enhanced independently of the NK cell 
maturation state. Analysis of competitive bone marrow  chimaeras 
revealed that IL-1R8 regulates NK cell differentiation in a cell- 
autonomous way (Extended Data Fig. 2h–k). Along the same line, 
co-culture experiments of NK cells with lipopolysaccharide (LPS)- or 
CpG-primed dendritic cells showed that Il1r8−/− NK cells produced 
higher IFNγ levels irrespective of the dendritic cell genotype (Extended 
Data Fig. 2l).
IL-18 is a member of the IL-1 family, which plays an important role 
in NK cell differentiation and function1,14. Enhanced NK cell matu-
ration and effector function in Il1r8−/− mice was abolished by IL-18 
blockade or genetic deficiency but unaffected by IL-1R1-deficiency 
(Fig. 2h, i and Extended Data Fig. 3a, b). Co-housing and antibiotic 
treatment had no impact, thus excluding a role of microbiota15 in the 
phenotype of Il1r8−/− mice (Extended Data Fig. 3c, d).
The results reported above suggested that IL-1R8 regulated the 
IL-18 signalling pathway in NK cells and, indeed, an increased 
 phospho-IRAK4/IRAK4 ratio was induced by IL-18 in Il1r8−/− NK 
cells compared with wild-type NK cells, indicating unleashed early 
 signalling downstream of MyD88 and myddosome formation (Fig. 2j), 
consistent with the proposed molecular mode of action of IL-1R8 
(refs 1, 9, 16). Indeed, by stimulated emission depletion (STED) micros-
copy, we observed clustering of IL-1R8 and IL-18Rα (Extended Data 
Fig. 3e), in line with previous studies9. IL-1R8-deficiency also led to 
enhanced IL-18-dependent phosphorylation of S6 and JNK in NK 
cells, suggesting that IL-1R8 inhibited IL-18-dependent activation of 
the mTOR and JNK pathways (Fig. 2j), which control NK cell metabo-
lism, differentiation and activation17,18.
1Humanitas Clinical and Research Center, 20089 Rozzano, Italy. 2Department of Animal Pathology, Faculty of Veterinary Medicine, University of Milan, 20133 Milan, Italy. 3Department of 
Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele Milan, Italy. 4Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia. 5Dipartimento di Medicina Molecolare Istituto 
Pasteur-Fondazione Cenci Bolognetti, Università di Roma “La Sapienza”, 00161 Rome, Italy. 6IRCCS Neuromed, 86077 Pozzilli (IS), Italy. 7Cancer Research UK Manchester Institute, The University 
of Manchester, Manchester M20 4QL, UK. 8The William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK. †Present address: Cancer Research UK Manchester 
Institute, The University of Manchester, Manchester M20 4QL, UK.
*These authors contributed equally to this work.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Letter reSeArCH
2  N O V E m b E R  2 0 1 7  |  V O L  5 5 1  |  N A T U R E  |  1 1 1
To obtain a deeper insight into the impact of IL-1R8 deficiency on 
NK cell function and on the response to IL-18, RNA sequencing (RNA-
seq) analysis was conducted. IL-1R8 deficiency had a profound impact 
on the resting transcriptional profile of NK cells and on top on respon-
siveness to IL-18 (Fig. 2k, Extended Data Fig. 4a and Supplementary 
Table 1). The profile of IL-1R8-deficient cells includes activation path-
ways (for example, MAPK), adhesion molecules involved in cell-to-
cell interactions and cytotoxicity (ICAM-1), and increased production 
of selected chemokines (CCL4). The last of these may represent an 
NK-cell-based amplification loop of leukocyte recruitment, including 
NK cells themselves.
To investigate the role of IL-1R8 in human NK cells (Fig. 1a, b), 
we first retrospectively analysed its expression in relation to respon-
siveness to a combination of IL-18 and IL-12 in normal donors. We 
observed an inverse correlation between IL-1R8 levels and IFNγ 
 production by peripheral blood NK cells (r2 = 0.7969, P = 0.0012) 
(Fig. 2l). In  addition, IL-1R8 partial silencing in peripheral blood 
NK cells with small interfering RNA (siRNA) was associated with a 
 significant increase in IFNγ production (Fig. 2m) and upregulation of 
CD69 expression (not shown). These results suggest that in human NK 
cells, as in mouse counterparts, IL-1R8 serves as a negative  regulator of 
activation and that its inactivation unleashes human NK-cell effector 
function.
To assess the actual relevance of IL-1R8-mediated regulation of NK 
cells, anticancer and anti-viral resistance were examined. The liver is 
characterized by a high frequency of NK cells19. Therefore we focused 
on liver carcinogenesis. In a model of diethylnitrosamine-induced 
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Figure 1 | Expression of IL-1R8 in human and mouse NK cells.  
a, b, IL-1R8 protein expression in human primary NK cells and other 
leukocytes (a) and NK cell maturation stages (b). MFI, mean fluorescence 
intensity. c, d, Il1r8 mRNA expression in mouse primary NK cells and 
other leukocytes (c) and in sorted splenic NK cell subsets (d). * P < 0.05, 
* * P < 0.01, * * * P < 0.001, one-way analysis of variance (ANOVA). 
Mean ± s.e.m.
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Figure 2 | NK cell differentiation and function in IL-1R8-deficient mice. 
a, b, NK cell frequency and absolute number among leukocytes in Il1r8+/+ 
and Il1r8−/− mice. c, d, NK cell subsets (c) and KLRG1+ NK cells (d).  
e–g, IFNγ (e), granzyme B (f) and FasL (g) expression in stimulated NK 
cells. h, Splenic CD27low NK cell frequency upon IL-18 in vivo depletion.  
i, IFNγ production by Il1r8+/+ and Il1r8−/− NK cells upon co-culture  
with CpG-primed Il1r8+/+ dendritic cells and IL-18 blockade. j, IRAK4,  
S6 and JNK phosphorylation in NK cells upon stimulation with IL-18 
for 15 or 30 min. k, RNA-seq analysis of resting and IL-18-activated NK 
cells. Differentially expressed (P < 0.05) genes are shown. l, Correlation 
between IL-1R8 expression and IFNγ production in human peripheral 
blood NK cells. m, IL-1R8 expression and IFNγ production in human NK 
cells 7 days after transfection with control siRNA or IL-1R8-specific siRNA 
in duplicate. a–l, * P < 0.05, * * P < 0.01, * * * P < 0.001 between selected 
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hepatocellular carcinoma, IL-1R8-deficient male and female mice20 
were protected against the development of lesions, in terms of macro-
scopic number, size (Fig. 3a and Extended Data Fig. 5a, b) and histology 
(data not shown). The percentage and absolute number of NK cells, and 
the percentage of IFNγ + NK cells, were higher in Il1r8−/− hepatocel-
lular carcinoma-bearing mice (Fig. 3b, c and Extended Data Fig. 5c). 
Finally, increased levels of cytokines involved in anti-tumour immunity 
(for example, IFNγ ) and a reduction of pro-inflammatory cytokines 
associated with tumour promotion (IL-6, TNF , IL-1β , CCL2, CXCL1) 
were observed (Extended Data Table 1). Most importantly, the deple-
tion of NK cells abolished the protection against liver carcinogenesis 
observed in Il1r8−/− mice (Fig. 3d and Extended Data Fig. 5d).
Evidence suggests that NK cells can inhibit haematogenous cancer 
metastasis5. In a model of sarcoma (MN/MCA1) spontaneous lung 
metastasis, Il1r8−/− mice showed a reduced number of haematogenous 
metastases, whereas primary tumour growth was unaffected (Fig. 3e 
and Extended Data Fig. 5e, f). The frequency of total and mature 
CD27low NK cells was higher in Il1r8−/− lungs (Fig. 3f and data not 
shown). Assessment of lung metastasis at the time of euthanasia and 
in vivo imaging analysis (Fig. 3g and Extended Data Fig. 5e) showed 
that the protection was completely abolished in NK-cell-depleted 
Il1r8−/− mice. In addition, IL-18 or IFNγ neutralization abolished 
or markedly reduced the protection against metastasis observed 
in Il1r8−/− mice (Extended Data Fig. 5g). In contrast, depletion of 
CD4+/CD8+ cells or IL-17A, or deficiency of IL-1R1 (involved in 
T helper 17 cell development), did not affect the phenotype (Extended 
Data Fig. 5h, i).
Liver metastasis is a major problem in the progression of colorectal 
cancer. We therefore assessed the potential of Il1r8−/− NK cells to 
 protect against liver metastasis using the MC38 colon carcinoma line21. 
As shown in Fig. 3h, Il1r8−/− mice were protected against MC38 colon 
carcinoma liver metastasis. In addition, IL-18 genetic deficiency abro-
gated the protection against liver metastasis observed in Il1r8−/− mice 
(Extended Data Fig. 5j), thus indicating that the IL-1R8-dependent 
control of MC38-derived liver metastasis occurs through the IL-18/
IL-18R axis. To assess the primary role of Il1r8−/− NK cells in the  cancer 
protection, adoptive transfer was used (Extended Data Fig. 5k–m). 
Adoptive transfer of Il1r8+/+ NK cells had no effect on lung and liver 
metastasis. In contrast, adoptive transfer of Il1r8−/− NK cells signifi-
cantly and markedly reduced the number and volume of lung and liver 
metastases (Fig. 3i, j and Extended Data Fig. 5n). Given the natural 
history and clinical challenges of colorectal cancer, this observation has 
potential translational implications. Thus, IL-1R8 genetic inactivation 
unleashes NK-cell-mediated resistance to carcinogenesis in the liver 
and amplifies the anti-metastatic potential of these cells in liver and 
lung in a NK-cell-autonomous manner.
Finally, we investigated whether IL-1R8 affects NK cell anti-viral 
activity, focusing on murine cytomegalovirus (MCMV) infection22. As 
shown in Fig. 4a, liver viral titres were lower in Il1r8−/− than Il1r8+/+ 
mice, indicating that IL-1R8-deficiency was associated with a more 
efficient control of MCMV infection. The frequency of IFNγ + NK 
cells and degranulation (that is, the frequency of CD107a+ NK cells) 
were significantly higher in the spleen and liver of Il1r8−/− mice on 
day 1.5 after infection (Fig. 4b). On day 4.5 after infection, IFNγ + and 
CD107a+ NK cells were strongly reduced, in both spleen and liver, as 
a consequence of better control of viral spread (Fig. 4b). Consistent 
with a more efficient control of the infection, reduced levels of pro- 
inflammatory cytokines were observed in Il1r8−/− mice (Extended 
Data Fig. 6a). NK-cell adoptive transfer experiments were performed 
in MCMV-infected newborn mice that still did not have mature 
NK cells12. As shown in Fig. 4c, the adoptive transfer of Il1r8−/− NK 
cells conferred higher protection than Il1r8+/+ NK cells, with, for 
instance, four out of nine mice having no detectable virus titre in 
the brain.
NK cells belong to the complex, diverse realm of innate lymphoid 
cells (ILCs)23. Human and mouse non-NK ILCs express IL-1R8 mRNA 
and protein (ref. 24, our unpublished data and C. Jandus, personal 
communication). Preliminary experiments were conducted to assess 
the role of IL-1R8 in ILC function. In the MCMV infection model, 
Il1r8−/− ILC1 showed increased IFNγ production, but represented a 
minor population compared with NK cells and one-thirtieth that of 
Il1r8−/− IFNγ -producing cells (Fig. 4d); they are therefore unlikely to 
play a significant role in the phenotype. These results provide initial 
evidence that IL-1R8 has a regulatory function in ILCs. Further studies 
are required to assess its actual relevance in ILC diverse populations. 
Collectively, these results indicate that IL-1R8-deficient mice were 
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Figure 3 | NK-cell-mediated protection against liver carcinogenesis 
and metastasis in IL-1R8-deficient mice. a, Macroscopic score of liver 
lesions in male Il1r8+/+ and Il1r8−/− mice 6, 8, 10 and 12 months after 
diethylnitrosamine (DEN) injection. P values are given at the tops of 
graphs. b, Frequency and representative histological quantification of  
NK cell infiltrate in liver of tumour-bearing mice (original magnification 
20× ; scale bar, 100 μ m). c, Frequency of IFNγ + NK cells in liver of 
tumour-bearing mice. d, Macroscopic score of liver lesions in male mice 
upon NK cell depletion. e, Number of spontaneous lung metastases.  
f, NK cell frequency in the lungs of MN/MCA1 tumour-bearing mice.  
g, Number of lung metastases in MN/MCA1 tumour-bearing mice 
upon NK cell depletion. h, Number of liver metastases in MC38 colon 
carcinoma-bearing mice. i, j, Number of lung (i) and liver (j) metastases of 
Il1r8+/+ mice after adoptive transfer of Il1r8+/+ and Il1r8−/− NK cells. NT, 
not treated. a, d, Representative images of female livers are shown.  
a–j, Exact P values are given.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Letter reSeArCH
2  N O V E m b E R  2 0 1 7  |  V O L  5 5 1  |  N A T U R E  |  1 1 3
protected against MCMV infection and that protection was dependent 
on increased NK cell activation.
IL-1R8 deficiency was associated with exacerbated inflammatory and 
immune reactions under a variety of conditions1,10. NK cells engage in 
bidirectional interactions with macrophages, dendritic cells and other 
lymphocytes3,4,25,26. Therefore the role of NK cells in inflammatory and 
autoimmune conditions associated with IL-1R8 deficiency1,10 will need 
to be examined. IL-1R8-deficient mice show increased susceptibility 
to colitis and colitis-associated azoxymethane carcinogenesis27,28. The 
divergent impact on carcinogenesis of IL-1R8 deficiency in the intestine 
and liver is likely to reflect fundamental, tissue-dictated differences 
of immune mechanisms involved in carcinogenesis in these different 
anatomical sites. In particular, high numbers of NK cells are present in 
the liver19 and this physiological characteristic of this organ is likely to 
underlie this apparent divergence.
NK cells are generally not credited with playing a major role in the 
control of solid tumours6. Conversely there is evidence for a role of NK 
cells in the control of haematogenous lung metastasis5,29. The results 
presented here show that unleashing NK cells by genetic inactivation 
of IL-1R8 resulted in inhibition of liver carcinogenesis and protec-
tion against liver and lung metastasis. IL-1R8-deficient mice show 
exacerbated TLR and IL-1-driven inflammation10, and inflammation 
 promotes liver carcinogenesis30. Therefore, our results are probably an 
underestimate of the potential of removal of the NK cell checkpoint 
IL-1R8 against liver primary and metastatic tumours. Thus, NK cells 
have the potential to restrain solid cancer and metastasis, provided 
 critical, validated checkpoints such as IL-1R8 are removed and the 
 tissue immunological landscape is taken into account.
Online Content Methods, along with any additional Extended Data display items and 
Source Data, are available in the online version of the paper; references unique to 
these sections appear only in the online paper.
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mice. a, Viral titre in livers of Il1r8+/+ and Il1r8−/− infected mice.  
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units. b, Frequency of IFNγ + and CD107a+ NK cells of infected mice.  
c, Viral titres in newborn wild-type mice upon adoptive transfer of 
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of IFNγ + cells in the liver of MCMV-infected mice. a–d, Exact P values 
are given, determined by two-tailed Mann–Whitney U-test (a, c) or 
unpaired Student’s t-test (b, d). Median (a, c); mean ± s.e.m. (b, d).  
NT, not treated.
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MethOdS
Animals. All female and male mice used were on a C57BL/6J genetic background 
and were 8–12 weeks old, unless otherwise specified. Wild-type mice were obtained 
from Charles River Laboratories, Calco, Italy, or were littermates of Il1r8−/− mice. 
IL-1R8-deficient mice were generated as described31. Il1r1−/− mice were purchased 
from The Jackson Laboratory, Bar Harbour, Maine, USA. All colonies were housed 
and bred in the SPF animal facility of Humanitas Clinical and Research Center in 
individually ventilated cages. Il1r1−/−/Il1r8−/− mice were generated by crossing 
Il1r1−/− and Il1r8−/− mice. Il18−/−/Il1r8−/− were generated by crossing Il18−/− and 
Il1r8−/− mice. Mice were randomized on the basis of sex, age and weight.
Procedures involving animal handling and care conformed to protocols 
approved by the Humanitas Clinical and Research Center (Rozzano, Milan, Italy) 
in compliance with national (D.L. N.116, G.U., suppl. 40, 18-2-1992 and N. 26, G.U. 
March 4, 2014) and international law and policies (EEC Council Directive 2010/63/
EU, OJ L 276/33, 22-09-2010; National Institutes of Health Guide for the Care and 
Use of Laboratory Animals, US National Research Council, 2011). The study was 
approved by the Italian Ministry of Health (approval number 43/2012-B, issued 
on the 8 February 2012, and number 828/2015-PR, issued on the 7 August 2015). 
All efforts were made to minimize the number of animals used and their suffering. 
In most in vivo experiments, the investigators were unaware of the genotype of the 
experimental groups.
Human primary cells. Human peripheral mononuclear cells were isolated from 
peripheral blood of healthy donors, upon approval by the Humanitas Research 
Hospital Ethical Committee. Peripheral mononuclear cells were obtained through 
a Ficoll density gradient centrifugation (GE Healthcare Biosciences). NK cells 
were then purified by a negative selection, using a magnetic cell sorting  technique 
according to the protocols given by the manufacturer (EasySep Human NK Cell 
Enrichment Kit, Stem Cell Technology). Human monocytes were obtained from 
peripheral blood of healthy donors by two-step gradient centrifugation, first 
by Ficoll and then by Percoll (65% iso-osmotic; Pharmacia, Uppsala, Sweden). 
Residual T and B cells were removed from the monocyte fraction by plastic 
adherence. Monocytes were cultured in RPMI-1640 medium supplemented with 
10% fetal bovine serum (FBS), 1% l-glutamine, 1% penicillin/streptomycin and 
100 ng ml−1 M-CSF (Peprotech) for 7 days to generate resting macrophages. T and 
B cells were obtained from peripheral blood of healthy donors using RosetteSep 
Human T Cell Enrichment Cocktail and RosetteSep Human B Cell Enrichment 
Cocktail (Stem Cell Technology), following the manufacturer’s instructions. 
Neutrophils were enriched from Ficoll-isolated granulocytes, using an EasySep 
Human Neutrophil Enrichment Kit (StemCell Technologies), according to the 
manufacturer’s instructions.
To analyse pluripotent haematopoietic stem cells and NK cell precursors, human 
bone marrow mononuclear cells were collected from Humanitas Biobank, upon 
approval by the Humanitas Research Hospital Ethical Committee (authorization 
1516, issued on 26 February 2016). Frozen samples were thawed and vitality was 
assessed by trypan blue and Aqua LIVE/Dead-405 nm staining (Invitrogen), before 
flow cytometry analysis.
Informed consent was obtained from all participants.
Fluorescence-activated cell sorting (FACS) analysis. Single-cell suspensions of 
bone  marrow, blood, spleen, lung and liver were obtained and stained. A repre-
sentative NK cell gating strategy is reported in Supplementary Fig. 1. A Foxp3/
Transcription Factor Staining Buffer Set (eBioscience) was used for  intracellular 
staining of granzyme B and perforin. Cytofix/Cytoperm (BD Biosciences) 
was used for intracellular staining of IFNγ . Liver ILC1 were  identified as 
NK1.1+CD3−CD49a+CD49b− cells. Formalin 4% and methanol 100% were 
used for intracellular staining of IRAK4, pIRAK4, pS6 and JNK. The following 
mouse antibodies were used: CD45-BV605, -BV650 or -PerCp-Cy5.5 (clone 
30-F11); CD45.1-BV650 (clone A20); CD45.2-APC, -BV421 (clone 104); CD3e-
PerCP-Cy5.5 or -APC (clone 145-2C11); CD19-PerCP-Cy5.5, -eFluor450 (clone 
1D3); NK1.1-PE, -APC, -eFluor450 or -Biotin (clone PK136); CD11b-BV421, 
-BV450, -BV785 (clone M1/70); CD27-FITC or -APC-eFluor780 (clone LG.7F9); 
CD4-FITC (clone RM 4-5); CD8-PE (clone 53-6.7); KLRG-1-BV421 (clone 2F1); 
NKG2D-APC (clone CX5); DNAM-1-APC (clone 10E5); Ly49H-PECF594 (clone 
3D10); Granzyme B-PE (clone NGZB); Perforin-PE (clone eBioOMAK-D); IFNγ 
-Alexa700 or -APC (clone XMG1.2); CD107a-Alexa647 (clone 1D4B); FasL-APC 
(clone MFL3); Lineage Cell Detection Cocktail-Biotin; Sca-1-FITC (clone D7); 
CD117-PE or -Biotin (clone 3C11); CD127-eFluor450 (clone A7R34); CD135-
APC or –Biotin (clone A2F10.1); CD244-PE (clone 2B4); CD122-PE-CF594 
(clone TM-Beta1); CD49b-PE-Cy7 or Biotin (clone DX5), CD49a-APC (clone 
Ha31/8), from BD Bioscience, eBioscience, BioLegend or Miltenyi Biotec. The 
following human antibodies were used: CD56-PE (clone CMSSB); CD3-FITC 
(clone UCHT1); CD16-Pacific Blue (clone 3G8); CD34-PE-Vio770 (clone 
AC136); CD117-BV605 (clone 104D2); NKp46-BV786 (clone 9E2/NKp46); 
CD45-PerCP (clone 2D1); CD19-APC-H7 (clone SJ25C1); CD14-APC-H7 
(clone M5E2); CD66b-APC-Vio770 (clone REA306), from BD Bioscience, eBi-
oscience or Miltenyi Biotec. Biotinylated anti-hSIGIRR (R&D Systems) and 
streptavidin Alexa Fluor 647 (Invitrogen) were used to stain IL-1R8 in human 
cells. Human NKT cells were detected using PE-CD1d tetramers loaded with α 
GalCer (ProImmune, Oxford, UK). Antibodies to detect protein phosphorylation 
were as follows: p-IRAK4 Thr345/Ser346 (clone D6D7), IRAK4, p-S6-Alexa647 
Ser235/236 (clone D57.2.2E); p-SAPK/JNK Thr183/Tyr185 (clone 81E11), from 
Cell Signaling Technology. A goat anti- rabbit Alexa Fluor 647 secondary antibody 
(Invitrogen) was used to stain p-IRAK4, IRAK4 and p-SAPK/JNK. Results are 
reported as mean fluorescence intensity normalized on isotype control or fluo-
rescence minus one. Cell viability was determined by Aqua LIVE/Dead-405 nm 
staining (Invitrogen) or Fixable Viability Dye (FVD) eFluor 780 (eBioscience); 
negative cells were considered viable. Cells were analysed on an LSR Fortessa or 
FACSVerse (BD Bioscience). Data were analysed with FlowJo software (Treestar).
Quantitative PCR. Total RNA was extracted using Trizol reagent (Invitrogen) 
following the manufacturer’s recommendations. RNA was further purified using 
an miRNeasy RNA isolation kit (Qiagen) or Direct-zol RNA MiniPrep Plus 
(Zymo Research). cDNA was synthesized by reverse transcription using a High 
Capacity cDNA Archive Kit (Applied Biosystems) and quantitative real-time 
PCR was  performed using SybrGreen PCR Master Mix (Applied Biosystems) in a 
CFX96 Touch Real-Time PCR Detection System (Bio-Rad). PCR reactions were 
 performed with 10 ng of DNA. Data were analysed with the 2(−ΔCT) method. Data 
were normalized on the basis of GAPDH, β -actin or 18S expression, as indicated, 
determined in the same sample. Analysis of all samples was performed in duplicate. 
Primers were designed according to the published sequences and listed as follows: 
s18/S18: forward 5′ -ACT TTC GAT GGT AGT CGC CGT-3′ , reverse 5′ -CCT TGG 
ATG TGG TAG CCG TTT-3′ ; Gapdh/GAPDH: forward 5′ -GCA AAG TGG AGA 
TTG TTG CCA T-3′ , reverse 5′ -CCT TGA CTG TGC CGT TGA ATT T-3′ ;  Actb/ 
ACTB: forward 5′ -CCC AAG GCC AAC CGC GAG AAG AT-3′ , reverse 5′ -GTC 
CCG GCC AGC CAG GTC CAG-3′ ; Il1r8: forward 5′ -AGA GGT CCC AGA AGA 
GCC AT-3′ , reverse 5′ -AAG CAA CTT CTC TGC CAA GG-3′ ; IL1R8: forward 
5′ -ATG TCA AGT GCC GTC TCA ACG-3′ , reverse 5′ -GCT GCG GCT TTA GGA 
TGA AGT-3′ ; Il1r1: forward 5′ -TGC TGT CGC TGG AGA TTG AC-3′ , reverse 
5′ -TGG AGT AAG AGG ACA CTT GCG AA-3′ ; Il1r2: forward 5′ -AGT GTG 
CCC TGA CCT GAA AGA-3′ , reverse 5′ -TCC AAG AGT ATG GCG CCC T-3′ ; 
Il1r3: forward 5′ -GGC TGG CCC GAT AAG GAT-3′ , reverse 5′ -GTC CCC AGT 
CAT CAC AGC G-3′ ; Il1r4: forward 5′ -GAA TGG GAC TTT GGG CTT TG-3′ , 
reverse 5′ -GAC CCC AGG ACG ATT TAC TGC-3′ ; Il1r5: forward 5′ -GCT CGC 
CCA GAG TCA CTT TT-3′ , reverse 5′ -GCG ACG ATC ATT TCC GAC TT-3′ ; 
Il1r6: forward 5′ -GCT TTT CGT GGC AGC AGA TAC-3′ , reverse 5′ -CAG ATT 
TAC TGC CCC GTT TGT T-3′ ; 16S: forward 5′ -AGA GTT TGA TCC TGG CTC 
AG-3′ , reverse 5′ -GGC TGC TGG CAC GTA GTT AG-3′ .
Purification of mouse leukocytes. Splenic NK cells and bone marrow  neutrophils 
were enriched by MACS according to the manufacturer’s instructions (Miltenyi 
Biotec). Purity of NK cells was about 90% as determined by FACS. The purity 
of neutrophils was ≥ 97.5%. NK cells were stained (CD45-BV650, NK1.1-PE, 
CD3e-APC, CD11b-BV421, CD27-FITC) and sorted on a FACSAria cell 
sorter (BD Bioscience) to obtain high-purity NK cells and NK cell popu-
lations (CD11blowCD27low, CD11blowCD27high, CD11bhighCD27high and 
CD11bhighCD27low). Splenic B and T lymphocytes were stained (CD45-PerCP, 
CD3e-APC, CD4-FITC, CD8-PE, CD19-eFluor450) and sorted. The purity of each 
population was ≥ 98%. Resulting cells were processed for mRNA extraction or 
used for adoptive transfer or co-culture experiments. In vitro-derived macrophages 
were obtained from bone marrow total cells. Bone marrow cells were cultured in 
RPMI-1640 medium supplemented with 10% FBS, 1% l-glutamine, 1% penicillin/
streptomycin and 100 ng ml−1 M-CSF (Peprotech) for 7 days to generate resting 
macrophages. Bone marrow cells were cultured in RPMI-1640 medium supple-
mented with 10% FBS, 1% l-glutamine, 1% penicillin/streptomycin and 20 ng ml−1 
GM-CSF (Peprotech) for 7 days to generate dendritic cells.
Confocal microscopy. Mouse splenic NK cells were enriched by magnetic cell 
sorting, left to adhere on poly-d-lysine (Sigma-Aldrich) coated coverslips, fixed 
with 4% PFA, permeabilized with 0.1% Triton X-100 and incubated with blocking 
buffer (5% normal donkey serum (Sigma-Aldrich), 2% BSA, 0.05% Tween). Cells 
were then stained with biotin-conjugated goat polyclonal anti-SIGIRR antibody 
or biotin-conjugated normal goat IgG as control (both R&D Systems) (10 μ g ml−1) 
followed by Alexa Fluor 488-conjugated donkey anti-goat IgG antibody (Molecular 
Probes) and 4′ ,6-diamidino-2-phenylindole (DAPI) (Invitrogen). Coverslips were 
mounted with the antifade medium FluorPreserve Reagent (EMD Millipore) and 
analysed with an Olympus Fluoview FV1000 laser scanning confocal microscope 
with a 40× oil immersion lens (numerical aperture 1.3).
STED microscopy. Human NK cells were enriched and left to adhere on poly-
d-lysine (Sigma-Aldrich) -coated coverslips, stimulated with IL-18 (50 ng ml−1; 
1 min, 5 min, 10 min), fixed with 4% PFA, incubated with 5% normal donkey serum 
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(Sigma-Aldrich), 2% BSA, 0.05% Tween in PBS2+ (pH 7.4) (blocking buffer), 
and then with biotin-conjugated goat polyclonal anti-human IL-1R8 antibody or 
biotin-conjugated normal goat IgG (all from R&D Systems) and mouse  monoclonal 
anti-IL-18Rα (Clone 70625; R&D Systems) or mouse IgG1 (Invitrogen), all diluted 
at 5 μ g ml−1 in blocking buffer, followed by Alexa Fluor 488-conjugated donkey 
anti-goat IgG antibody and Alexa Fluor 555 donkey anti-mouse IgG antibody (both 
from Molecular Probes). Mowiol was used as mounting medium. STED xyz images 
were acquired in a unidirectional mode with a Leica SP8 STED3X confocal micro-
scope system. Alexa Fluor 488 was excited with a 488 nm argon laser and emission 
collected from 505 to 550 nm applying a gating between 0.4 and 7 ns to avoid 
collection of reflection and autofluorescence. Alexa Fluor 555 was excited with a 
555/547 nm-tuned white light laser and emission collected from 580 to 620 nm. 
Line sequential acquisition was applied to avoid fluorescence overlap. The 660 nm 
CW-depletion laser (80% of power) was used for both excitations. Images were 
acquired with Leica HC PL APO 100× /1.40 numerical aperture oil STED White 
objective at 572.3 milli absorption unit (mAU). CW-STED and gated CW-STED 
were applied to Alexa Fluor 488 and Alexa Fluor 555, respectively. Collected images 
were de-convolved with Huygens Professional software.
3′-mRNA sequencing and analysis. Splenic NK cells (from six mice per genotype 
and pooled in pairs) were purified as described above and stimulated with IL-18 
(MBL) (20 ng ml−1 for 4 h). RNA was prepared as described above. A QuantSeq 
3′ mRNA-seq Library Prep Kit for Illumina (Lexogen) was used to generate 
 libraries, which were sequenced on the NextSeq (Illumina; 75 bp PE). The fastq 
sequence files were assessed using the fastqc program. The reads were first trimmed 
using bbduk in the bbmap suite of software32 to remove the first 12 bases and 
a contaminant kmer discovery length of 13 was used for contaminant removal. 
Regions of length 20 or above with average quality of less than 10 were trimmed 
from the end of the read. The reads were then trimmed to remove trailing polyG 
and polyA runs using cutadapt33 and the quality of the remaining reads reassessed 
with fastqc. The trimmed reads were aligned to the mm10 genomic reference and 
reads assigned to features in the mm10 annotation using the STAR program34. 
Differential expression analysis used the generalized linear model functions in the 
R/bioconductor35 edgeR package36 with TMM normalization. Gene set analysis 
used the romer37 function in the R/bioconductor package limma38. Metascape 
(http://metascape.org) was used to enrich genes for Gene Ontology biological 
processes, KEGG Pathway and Reactome Gene Sets.
Measurement of cytokines. A BD Cytometric Bead Array (CBA) mouse inflamma-
tion kit (BD) or Duoset ELISA kits (R&D Systems) were used to measure cytokines.
In vitro functional assays. Total mouse splenocytes or enriched mouse or human 
NK cells were cultured in RPMI-1640 medium supplemented with 10% FBS 
1% l-glutamine, 1% penicillin/streptomycin and treated with IL-2, IL-12, IL-15 
(Peprotech), IL-18 (MBL), IL-1β (Peprotech) and PMA-Ionomycin (Sigma-
Aldrich), as specified. FasL expression was evaluated upon treatment for 45 min with 
IL-18 (50 ng ml−1), IL-15 (50 ng ml−1), IL-2 (20 ng ml−1) and IL-12 (10 ng ml−1). 
IFNγ production was analysed upon 16 h of treatment with IL-12 (20 ng ml−1) 
and IL-18 (20 ng ml−1) or IL-1β (20 ng ml−1), by intracellular staining using a BD 
Cytofix/Cytoperm Fixation/Permeabilization Kit, following the manufacturer’s 
instructions, or by ELISA. Granzyme B and perforin intracellular staining was 
performed upon 18 h of stimulation with IL-12 (10 ng ml−1), IL-15 (10 ng ml−1) 
and IL-18 (50 ng ml−1−1), using a Foxp3/Transcription Factor Staining Buffer Set 
(eBioscience). CD107a-Alexa Fluor 647 antibody was added during the 4 h culture 
and analysed by flow cytometry. BD GolgiPlug (containing Brefeldin) and BD 
GolgiStop (containing Monensin) were added 4 h before intracellular staining. 
PMA (50 ng ml−1) and ionomycin (1 μ g ml−1) were added 4 h before intracellular 
staining, when specified.
NK–dendritic-cell co-culture experiments were performed as previously 
described39. Dendritic cells were treated with LPS from Escherichia coli O55:B5 
(Sigma-Aldrich; 1 μ g ml−1) or CpG ODN 1826 (Invivogen; 3 μ g ml−1) and with 
anti-mIL-18 neutralizing antibody (BioXCell, Clone YIGIF74-1G7; 5 μ g ml−1) or 
Rat Isotype Control (BioXCell, Clone 2A3).
IFNγ and CD107a expression upon viral infection was analysed by flow 
 cytometry upon 4 h treatment with BD GolgiPlug, BD GolgiStop and IL-2 
(500 U ml−1).
Phosphorylation of IRAK4, S6 and JNK was analysed upon 15–30 min stimu-
lation with IL-18 (10 ng ml−1).
Human primary NK cell transfection. Human NK cells were enriched from 
peripheral blood of healthy donors and transfected with Dharmacon Acell siRNA 
(GE Healthcare) using Accell delivery medium (GE Healthcare), following the 
manufacturer’s instructions. SIGIRR-specific siRNA (1 μ M) (On-Target Plus; 
Dharmacon, GE Healthcare) comprised 250 nM of the four following antisense 
sequences: I, AGU UUC GCG AGC CGA GAU CUU; II, UAC CAG AGC AGC 
ACG UUG AUU; III, UGA CCC AGG AGU ACU CGU GUU; IV, CUU CCC 
GUC GUU UAU CUC CUU (all 5′ to 3′ ).
Generation of bone marrow chimaeras. Il1r8−/− and Il1r8+/+ mice were lethally 
irradiated with a total dose of 900 cGy. Two hours later, mice were injected in 
the retro-orbital plexus with 4 × 106 nucleated bone marrow cells obtained by 
 flushing of the cavity of freshly dissected femurs from wild-type or Il1r8−/− donors. 
Competitive bone marrow chimaeric mice were generated by reconstituting 
 recipient mice with 50% CD45.1 Il1r8+/+ and 50% CD45.2 Il1r8−/− bone marrow 
cells. Recipient mice received gentamycin (0.8 mg ml−1 in drinking water) starting 
10 days before irradiation and for 2 weeks after irradiation. NK cells of chimaeric 
mice were analysed 8 weeks after bone marrow transplantation.
Depletion and blocking experiments. Mice were treated intraperitoneally with 
200 μ g of specific mAbs (mouse anti-NK1.1, clone PK136; mouse isotype Control, 
clone C1.18.4; rat anti-mIL-18, clone YIGIF74-1G7; rat isotype Control, clone 2A3; 
rat anti-IFNγ , clone XMG1.2; rat IgG1 HRPN; mouse anti-IL-17A, clone 17F3; 
mouse isotype Control, clone MOPC-21; rat anti-CD4/CD8, clone GK1.5/YTS; 
rat isotype Control, clone LTF-2 (all from BioXCell)) and then with 100 μ g once 
(anti-NK1.1) or three times (anti-IL-18, anti-IFNγ , anti-IL-17A, anti-CD4/CD8) 
a week for the entire duration of the experiment.
Microflora depletion. Six-week-old mice were treated every day for 5 weeks by oral 
gavage with a cocktail of antibiotics (ampicillin (Pfizer) 10 mg ml−1, vancomycin 
(PharmaTech Italia) 10 mg ml−1, metronidazol (Società Prodotti Antibiotici) 
5 mg ml−1 and neomycin (Sigma-Aldrich) 10 mg ml−1). Control mice were treated 
with drinking water. A gavage volume of 10 ml/kg (body weight) was delivered 
with a stainless-steel tube without prior sedation of mice. DNA was isolated from 
bacterial faecal pellets with a PowerSoil DNA Isolation Kit (MO BIO Laboratories) 
and quantified by spectrophotometry at 260 nm. PCR was performed with 10 ng of 
DNA using SybrGreen PCR Master Mix (Applied Biosystems) in a CFX96 Touch 
Real-Time PCR Detection System (Bio-Rad). Data were analysed with the 2(−ΔCT) 
method (Applied Biosystems, Real-Time PCR Applications Guide).
Cancer models. Mice were injected intraperitoneally with 25 mg/kg (body weight) 
of diethylnitrosamine (Sigma) at 15 days of age. They were euthanized 6, 8, 10 or 
12 months later, to analyse liver cancer. Liver cancer score was based on the number 
and volume of lesions (0: no lesions; 1: lesion number < 3, or lesion dimension 
< 3 mm; 2: lesion number < 5, or lesion dimension < 5 mm; 3: lesion number < 10, 
or lesion dimension < 10 mm; 4: lesion number < 15, or lesion dimension < 10 mm; 
5: lesion number > 15, or lesion dimension > 10 mm). Lung metastasis experiments 
were performed injecting intramuscularly the 3-MCA-derived mycoplasma-free 
sarcoma cell line MN/MCA1 (105 cells per mouse in 100 μ l PBS)40. Primary tumour 
growth was monitored twice a week, and lung metastases were assessed by in vivo 
imaging and by macroscopic counting at the time of being euthanized 25 days after 
injection. Liver metastases were generated by injecting intrasplenically 1.5 × 105 
mycoplasma-free colon carcinoma cells (MC38)21. Mice were euthanized 12 days 
after injection and liver metastases were counted macroscopically. MC38 cells 
were received from ATCC just before use. MN/MCA1 cells were authenticated 
 morphologically by microscopy in vitro and by histology ex vivo. Tumour size limit 
at which mice were euthanized was based on major diameter (not more than 2 cm).
Viral infections. Mice were injected intravenously with 5 × 105 plaque-forming 
units of the tissue-culture-grown virus in PBS. Bacterial artificial chromosome- 
derived MCMV strain MW97.01 has been previously shown to be biologically 
equivalent to MCMV strain Smith (VR-1399) and is hereafter referred to as wild-
type MCMV41. Mice were euthanized 1.5 and 4.5 days after infection and viral 
titre was assessed by plaque assay, as previously described42,43. Newborn mice were 
infected intraperitoneally with 2,000 plaque-forming units of the MCMV strain 
MW97.01 and euthanized at day 7 after infection. Viral titre was assessed by plaque 
assay, as previously described42,43.
Adoptive transfer. One million Il1r8+/+ or Il1r8−/− sorted NK cells were injected 
intravenously in wild-type adult mice 5 h before MN/MCA or MC38 injection, 
or intraperitoneally in newborn mice 48 h after MCMV injection. Adoptively 
transferred NK cell engraftment, proliferative capacity and functionality (IFNγ 
production and degranulation after ex vivo stimulation) were assessed 3 and 
7 days after injection.
In vivo proliferation. In vivo proliferation was measured using a Click-iT Edu 
Flow Cytometry Assay Kit (Invitrogen). Edu was injected intraperitoneally (0.5 mg 
per mouse), mice were euthanized 24 h later and cells were stained following the 
manufacturer’s instructions and analysed by flow cytometry.
Immunohistochemistry. Frozen liver tissues were cut at 8 mm and then fixed 
with 4% PFA. Endogenous peroxidases were blocked with 0.03% H2O2 for 5 min 
and unspecific binding sites were blocked with PBS + 1% FBS for 1 h. Tissues were 
stained with polyclonal goat anti-mouse NKp46/NCR1 (R&D Systems) and a Goat-
on-Rodent HRP polymer kit (GHP516, Biocare Medical) was used as secondary 
antibody. Reactions were developed with 3,3′ -diaminobenzidine (Biocare Medical) 
and then slides were counterstained with haematoxylin. Slides were mounted with 
eukitt (Sigma-Aldrich). Images at 20× magnification were analysed with cell^F 
software (Olympus).
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In vivo imaging. After feeding with AIN-76A alfalfa-free diet (Mucedola, 
Italy) for 2 weeks to reduce fluorescence background, mice were intravenously 
injected with XenoLight RediJect 2-deoxyglucosone (PerkinElmer) and 24 h later 
2- deoxyglucosone fluorescence was measured using a Fluorescence Molecular 
Tomography system (FMT 2000, Perkin Elmer). Acquired images were subse-
quently analysed with TrueQuant 3.1 analysis software (Perkin Elmer).
Data availability. The data discussed in this publication have been deposited in 
the NCBI Gene Expression Omnibus (GEO) under accession number GSE105043, 
or from the corresponding author. Source Data for Figs 3, 4 and Extended Data 
Fig. 5 are provided.
Statistical analysis. For animal studies, sample size was defined on the basis of 
past experience on cancer and infection models, to detect differences of 20% or 
greater between the groups (10% significance level and 80% power). Values were 
expressed as mean ± s.e.m. or median of biological replicates, as specified. One-
way ANOVA or a Kruskal–Wallis test were used to compare multiple groups. 
A two-sided unpaired Student’s t-test was used to compare unmatched groups with 
Gaussian distribution and Welch’s correction was applied in cases of significantly 
different variance. A Mann–Whitney U-test was used in cases of non-Gaussian 
distribution. A ROUT test was applied to exclude outliers. P ≤ 0.05 was considered 
significant. Statistics were calculated with GraphPad Prism version 6, GraphPad 
Software.
Statistics and reproducibility. Figure 1a, n = 4 (B cells), n = 5 (NKT cells), n = 9 
(T cells), n = 10 (NK cells) donors; Fig. 1b, n = 5 donors; Fig. 1c, n = 8 (NK cells) 
or n = 4 (T cells) or n = 3 (other leukocytes) mice; Fig. 1d, n = 5 mice. Figure 1b, 
Representative experiment out of six performed. Figure 1a, c, d, one experiment 
performed.
Figure 2a, b, n = 8 or n = 7 (spleen, Il1r8+/+ liver) or n = 6 (Il1r8−/− liver) mice; 
Fig. 2c, n = 6 mice; Fig. 2d, n = 9 (Il1r8+/+) or n = 6 (Il1r8−/−) mice; Fig. 2e, n = 5 
mice; Fig. 2f, n = 6 mice; Fig. 2g, n = 4 mice; Fig. 2h, n = 5 mice; Fig. 2i, n = 10 wells; 
Fig. 2j, n = 4 (IRAK4), n = 6 or n = 5 (S6 Il1r8−/−) or n = 7 (JNK Il1r8−/−) mice; 
Fig. 2k, n = 3 mice; Fig. 2l, n = 9 healthy donors; Fig. 2m, n = 4 healthy donors. 
Representative experiments out of three (Fig. 2a, b), five (Fig. 2c), two (Fig. 2d, j), 
four (Fig. 2e) performed. Fig. 2f–m, one experiment performed.
Figure 3a, n = 8, 10, 11, 13, 14 mice; Fig. 3b, c, n = 6 mice; Fig. 3d, n = 10, 12, 13 
mice; Fig. 3e, n = 10, 11 mice; Fig. 3f, n = 5, 6, 7 mice; Fig. 3g, n = 9, 10 mice; Fig. 3h, 
n = 5, 6 mice; Fig. 3i, n = 9, 10 or 12 mice; Fig. 3j, n = 6 mice. Representative 
 experiments out of 6 (Fig. 3e), 3 (Fig. 3a), 2 (Fig. 3d, f, g, h, i). Fig. 3b, c, j, one 
experiment performed.
Figure 4a, b, n = 5 mice; Fig. 4c, n = 6, n = 9 mice; Fig. 4d, n = 4 mice. Fig. 4a, 
two experiments were performed. Fig. 4b–d, one experiment was performed.
31. Garlanda, C. et al. Intestinal inflammation in mice deficient in Tir8, an 
inhibitory member of the IL-1 receptor family. Proc. Natl Acad. Sci. USA 101, 
3522–3526 (2004).
32. Bushnell, B. Bbmap: a fast, accurate, splice-aware aligner (Ernest Orlando 
Lawrence Berkeley National Laboratory, 2014).
33. Martin, M. Cutadapt removes adapter sequences from high-throughput 
sequencing reads. EMBnet.journal 17, http://dx.doi.org/10.14806/ej.17.1.200 
(2011).
34. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 
15–21 (2013).
35. Gentleman, R. C. et al. Bioconductor: open software development for 
computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
36. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package 
for differential expression analysis of digital gene expression data. 
Bioinformatics 26, 139–140 (2010).
37. Majewski, I. J. et al. Opposing roles of polycomb repressive complexes in 
hematopoietic stem and progenitor cells. Blood 116, 731–739 (2010).
38. Ritchie, M. E. et al. limma powers differential expression analyses for 
RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
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node-resident NK cells into anti-tumor effectors. EMBO Mol. Med. 8, 
1039–1051 (2016).
40. Giavazzi, R., Alessandri, G., Spreafico, F., Garattini, S. & Mantovani, A. 
Metastasizing capacity of tumour cells from spontaneous metastases of 
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Extended Data Figure 1 | Expression of IL-1R8 in human and mouse 
NK cells. a, b, IL1R8 mRNA expression in human primary NK cells, 
compared with T and B cells, neutrophils, monocytes and in vitro-
derived macrophages (a) and in human primary NK cell maturation 
stages (CD56brCD16−, CD56brCD16+, CD56dimCD16+), and in the 
CD56dimCD16− subset (b). c, Representative FACS plot of human NK cell 
subsets and histograms of IL-1R8 expression in NK cell subsets. d, IL-1R8 
protein expression in human bone marrow precursors and mature cells. 
e, ILR family member (Il1r1, Il1r2, Il1r3, Il1r4, Il1r5, Il1r6, Il1r8) mRNA 
expression in mouse primary NK cells isolated from the spleen. f, IL-1R8 
protein expression in mouse NK cells by confocal microscopy. Scale bars, 
10 μ m. g, Representative FACS plot of mouse NK cell subsets. a, b, d,  
* P < 0.05, * * P < 0.01, * * * P < 0.001. One-way ANOVA. Mean ± s.e.m.  
a, n = 6 (NK and B cells) or n = 4 donors; b, n = 5 donors; d, n = 4 donors; 
e, n = 2 mice; f, representative images out of four collected per group.  
a, b, d–f, One experiment performed.
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Extended Data Figure 2 | See next page for caption.
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Extended Data Figure 2 | Phenotypic analysis of Il1r8−/− NK cells.  
a, b, Representative plot of fluorescence-activated cell sorting of mouse 
NK cell subsets in Il1r8+/+ and Il1r8−/− mice (a) and histograms of KLRG1 
expression in NK cells (b). c, d, NK absolute number and NK cell subsets 
(DN, CD11blow, DP and CD27low) in bone marrow, spleen and blood of 
Il1r8+/+ and Il1r8−/− newborn mice at 2 (c) and 3 (d) weeks of age.  
e, Frequency of bone marrow precursors in Il1r8+/+ and Il1r8−/− mice.  
f, NKG2D, DNAM-1 and LY49H expression in peripheral NK cells and 
NK cell subsets of Il1r8+/+ and Il1r8−/− mice. g, Frequency of splenic 
Perforin+ NK cell subsets upon stimulation in Il1r8+/+ and Il1r8−/− mice.  
h, i, Peripheral NK cell absolute number (h) and CD27low NK cell 
frequency (i) in bone marrow chimaeric mice upon reconstitution  
(9 weeks). j, k, Peripheral NK cell (j) and NK cell subset (k) frequency  
in competitive chimaeric mice transplanted with 50% of Il1r8+/+  
CD45.1 cells and 50% of Il1r8−/− CD45.2 cells upon reconstitution  
(9 weeks). Upon reconstitution, a defective engraftment (12% instead 
of 50% engraftment) of Il1r8−/− stem cells was observed in competitive 
conditions. l, IFNγ production by Il1r8+/+ and Il1r8−/− NK cells upon 
co-culture with LPS- or CpG-primed Il1r8+/+ and Il1r8−/− dendritic 
cells. c–l, * P < 0.05, * * P < 0.01, * * * P < 0.001 between selected relevant 
comparisons, two-tailed unpaired Student’s t-test. Centre values and error 
bars, mean ± s.e.m. At least five animals per group were used. c, d, Three 
pooled experiments; e–l, one experiment was performed.
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Extended Data Figure 3 | Mechanism of IL-1R8-dependent regulation 
of NK cells. a, Splenic CD27low NK cell frequency in wild-type, Il1r8−/−, 
Il18−/− and Il18−/−/Il1r8−/− mice. b, Peripheral CD27low NK cell 
frequency in wild-type, Il1r8−/−, Il1r1−/− and Il1r8−/−Il1r1−/− mice (left) 
and IFNγ production by splenic NK cells after IL-12 and IL-1β or IL-18 
stimulation (right). c, d, Splenic CD27low NK cell frequency in Il1r8+/+ 
and Il1r8−/− mice upon commensal flora depletion (c) and breeding 
in co-housing conditions (d). e, STED microscopy of human NK cells 
stimulated with IL-18. Magnification bar, 2 μ m. a–d, * P < 0.05, * * P < 0.01, 
* * * P < 0.001 between selected relevant comparisons, two-tailed unpaired 
Student’s t-test; Centre values and error bars, mean ± s.e.m. a, n = 3, 
5, or 6 mice; at least five animals per group were used (b–d). a–d, One 
experiment was performed. e, Representative images out of three collected 
from two donors.
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Extended Data Figure 4 | RNA-seq analysis of Il1r8+/+ and Il1r8−/− NK cells. Metascape analysis of enriched gene pathways of resting and IL-18-
activated Il1r8+/+ and Il1r8−/− NK cells. See also Supplementary Table 1 and data deposited in the NCBI Gene Expression Omnibus under accession 
number GSE105043.
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Extended Data Figure 5 | NK-cell-mediated resistance to hepatocellular 
carcinoma and metastasis in IL-1R8-deficient mice. a, Macroscopic 
score of liver lesions in female Il1r8+/+ and Il1r8−/− mice 6, 10 and 
12 months after diethylnitrosamine (DEN) injection. b, Incidence of 
hepatocellular carcinoma in Il1r8+/+ and Il1r8−/− female and male mice. 
c, Frequency of IFNγ + NK cells in spleen of Il1r8+/+ and Il1r8−/− tumour-
bearing mice. d, Macroscopic score of liver lesions in female Il1r8+/+ 
and Il1r8−/− mice upon NK cell depletion. e, 2-Deoxyglucosone (2-DG) 
quantification in lungs of Il1r8+/+ and Il1r8−/− tumour-bearing mice upon 
NK cell depletion. f, Primary tumour growth in Il1r8+/+ and Il1r8−/− 
mice (25 days after MN/MCA1 cell line injection). g, Number of lung 
metastases in Il1r8+/+ and Il1r8−/− MN/MCA1 sarcoma-bearing mice 
upon IFNγ or IL-18 neutralization. h, Volume of lung metastases  
in Il1r8+/+ and Il1r8−/− MN/MCA1-bearing mice upon depletion of  
IL-17A or CD4+/CD8+ cells. i, Number of lung metastases in Il1r8+/+ and 
Il1r8−/−, Il1r1−/−, Il1r1−/−/Il1r8−/− MN/MCA1-bearing mice. j, Number 
of liver metastases in Il1r8+/+, Il1r8−/−, Il18−/−, Il18−/−Il1r8−/− MC38 
colon carcinoma-bearing mice. k, Il1r8+/+ and Il1r8−/− NK cell absolute 
number 3 or 7 days after adoptive transfer. l, In vivo Il1r8+/+ and Il1r8−/− 
NK cell proliferation 3 days after adoptive transfer. m, Ex vivo IFNγ 
production and degranulation upon 4 h stimulation with PMA-ionomycin, 
IL-12 and IL-18 in adoptively transferred Il1r8+/+ and Il1r8−/− NK cells.  
n, Volume of lung metastases in Il1r8+/+ MN/MCA1 sarcoma-bearing 
mice after adoptive transfer of Il1r8+/+ and Il1r8−/− NK cells.  
a, c–e, g–j, m–n, * P < 0.05, * * P < 0.01, * * * P < 0.001 between selected 
relevant comparisons, two-tailed unpaired Student’s t-test or Mann–
Whitney U-test. #P < 0.05, ##P < 0.01, Kruskal–Wallis and Dunn’s 
multiple comparison test. Centre values and error bars, mean ± s.e.m.  
a, n = 9, 10, 11, 18, 21 mice; b, n = 8–21 mice; c, n = 6 mice; d, n = 10, 
12, 13 mice; e, n = 4 (Il1r8−/− isotype) or n = 5; f, n = 10; g, n = 6, 7, 9, 10 
mice; h, n = 5, 6, 12 mice; i, n = 6, 8, 10 mice; j, n = 4, 5, 7 mice;  
k, l, m, n = 3 mice; n, n = 9, 10, 12 mice. Representative experiment  
out of three (a, b), 2 (d), 6 (f), or one (c, e, g–n) experiments performed. 
NT, not treated.
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Extended Data Figure 6 | NK-cell-mediated anti-viral resistance in IL-1R8-deficient mice. Cytokine serum levels in Il1r8+/+ and Il1r8−/− infected 
mice (1.5 and 4.5 days after infection). * P < 0.05, * * P < 0.01, * * * P < 0.001, unpaired Student’s t-test. Centre values and error bars, mean ± s.e.m.;  
n = 5 mice. One experiment was performed.
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extended data table 1 | Serum cytokine and liver enzyme levels in hepatocellular carcinoma-bearing mice
* Samples with undetectable levels were not included in the analysis.
* * Levels are U l−1.
* * * N = 5, 8 months after diethylnitrosamine (DEN) injection.
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`    Experimental design
1.   Sample size
Describe how sample size was determined. For animal studies, sample size was defined on the basis of past experience on 
cancer and infection models, in order to detect differences of 20% or grater 
between the groups (10% significance level and 80% power). 
2.   Data exclusions
Describe any data exclusions. ROUT test was applied to exclude outliers.
3.   Replication
Describe whether the experimental findings were 
reliably reproduced.
Most experiments were replicated several times with reproducible results as 
indicated in figure legend/Statistics and reproducibility.
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
Mice were randomized based on sex, age and weight.
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
In most in vivo experiments, the investigators were unaware of the genotype of 
the experimental groups. 
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
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`   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
Prism 6
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
`   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a for-profit company.
IL-1R8-deficient mice are available upon a MTA signature.
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
The following murine antibodies were used: CD45-BV605, -BV650 or -PerCp-Cy5.5 
(Clone 30-F11); CD45.1-BV650 (Clone A20); CD45.2-APC, -BV421 (Clone 104); 
CD3e-PerCP-Cy5.5 or -APC (Clone 145-2C11); CD19-PerCP-Cy5.5, -eFluor450 (Clone 
1D3); NK1.1-PE, -APC, -eFluor450 or –Biotin (Clone PK136); CD11b-BV421, -BV450, 
-BV785 (Clone M1/70); CD27-FITC or –APC-eFluor780 (Clone LG.7F9); CD4-FITC 
(Clone RM 4-5); CD8-PE (Clone 53-6.7); KLRG-1-BV421 (Clone 2F1); NKG2D-APC 
(Clone CX5); DNAM-1-APC (Clone 10E5); Ly49H-PECF594 (Clone 3D10); Granzyme 
B-PE (Clone NGZB); Perforin-PE (Clone eBioOMAK-D); IFNγ-Alexa700 or -APC (Clone 
XMG1.2); CD107a-Alexa647 (Clone 1D4B); FasL-APC (Clone MFL3);  Lineage Cell 
Detection Cocktail-Biotin; Sca-1-FITC (Clone D7); CD117-PE or -Biotin (Clone 3C11); 
CD127-eFluor450 (Clone A7R34); CD135-APC or –Biotin (Clone A2F10.1); CD244-PE 
(Clone 2B4); CD122-PE-CF594 (Clone TM-Beta1); CD49b-PE-Cy7 or Biotin (Clone 
DX5), CD49a-APC (Clone Ha31/8), from BD Bioscience, eBioscience, BioLegend or 
Miltenyi Biotec. Mouse anti-NK1.1, Clone PK136; Mouse Isotype Control, Clone 
C1.18.4; Rat anti-mIL-18, Clone YIGIF74-1G7; Rat Isotype Control, Clone 2A3; Rat 
anti-IFNγ, Clone XMG1.2; Rat IgG1 HRPN; Mouse anti-IL-17A, Clone 17F3; Mouse 
Isotype Control, Clone MOPC-21; Rat anti-CD4/CD8, Clone GK1.5/YTS; Rat Isotype 
Control, Clone LTF-2. 
The following human antibodies were used: CD56-PE (Clone CMSSB); CD3-FITC 
(Clone UCHT1); CD16-Pacific Blue (Clone 3G8); CD34-PE-Vio770 (Clone AC136); 
CD117-BV605 (Clone 104D2); NKp46-BV786 (Clone 9E2/NKp46); CD45-PerCP 
(Clone 2D1); CD19-APC-H7 (Clone SJ25C1); CD14-APC-H7 (Clone M5E2); CD66b-
APC-Vio770 (Clone REA306), from BD Bioscience, eBioscience or Miltenyi Biotec. 
Biotinylated anti-hSIGIRR (R&D Systems) and Streptavidin-Alexa647 (Invitrogen™) 
were used to stain IL-1R8 in human cells. Human NKT cells were detected using PE-
CD1d tetramers loaded with αGalCer (ProImmune, Oxford, UK). Antibodies to 
detect protein phosphorylation were as follows: p-IRAK4 Thr345/Ser346 (Clone 
D6D7), IRAK4, p-S6-Alexa647 Ser235/236 (Clone D57.2.2E); p-SAPK/JNK Thr183/
Tyr185 (Clone 81E11), from Cell Signaling Technology. A Goat anti-Rabbit-Alexa647 
secondary antibody (Invitrogen™) was used to stain p-IRAK4, IRAK4 and p-SAPK/
JNK. 
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10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. The following cell lines were used: 3-MCA derived mycoplasma-free sarcoma cell 
line MN/MCA1 and colon carcinoma cells (MC38) .
b.  Describe the method of cell line authentication used. MC38 cells were received from ATCC just before use. 
MN/MCA1 cells were  authenticated by checking morphology by microscopy after 
plating at different concentrations. A pathologist validated by histology sarcoma 
generated in vivo.
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
Cells  were tested for Mycoplasma and only Mycoplasma free cells were used.
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
NA
`    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived 
materials used in the study.
All female and male mice used were on a C57BL/6J genetic background and 8-12 
weeks-old, unless specified. Wild-type mice were obtained from Charles River 
Laboratories, Calco, Italy or were littermates of Il1r8-/- mice. IL-1R8-deficient mice 
were generated as described35. Il1r1-/- mice were purchased from The Jackson 
Labs, Bar Harbor ME, USA. All colonies were housed and bred in the SPF animal 
facility of Humanitas Clinical and Research Center in individually ventilated cages. 
Il1r1-/-/Il1r8-/- mice were generated by crossing Il1r1-/- and Il1r8-/- mice. Il18-/-/
Il1r8-/- were generated by crossing Il18-/- and Il1r8-/- mice. 
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
Human peripheral mononuclear cells (PBMCs) were isolated from peripheral blood 
of 30-50-year old male and female healthy donors, upon approval by Humanitas 
Research Hospital Ethical Committee.  
Human Bone Marrow mononuclear cells were collected from Humanitas Biobank, 
upon approval by Humanitas Research Hospital Ethical Committee (Authorization 
1516, issued on February 26, 2016).
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Flow Cytometry Reporting Summary
 Form fields will expand as needed. Please do not leave fields blank.
`    Data presentation
For all flow cytometry data, confirm that:
1.  The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
2.  The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of 
identical markers).
3.  All plots are contour plots with outliers or pseudocolor plots.
4.  A numerical value for number of cells or percentage (with statistics) is provided.
`    Methodological details
5.   Describe the sample preparation. Murine single-cell suspensions of BM, blood, spleen, lung and liver were 
obtained and stained. Human peripheral mononuclear cells (PBMCs) were 
isolated from peripheral blood of healthy donors, through a Ficoll density 
gradient centrifugation. Human Bone Marrow mononuclear cells were 
collected from Humanitas Biobank and thawed.
6.   Identify the instrument used for data collection. BD LSRFortessa (TM) 
BD FACSVerse (TM) 
BD FACSAria (TM)
7.   Describe the software used to collect and analyze 
the flow cytometry data.
FlowJo (9.3.2)
8.   Describe the abundance of the relevant cell 
populations within post-sort fractions.
Post-sort cells were 99.37% +/- 0.7% (SD) pure, as determined by 
reanalysing by FACS a fraction of sorted cells.
9.   Describe the gating strategy used. A relevant gating strategy for murine NK cells is described in 
Supplementary Figure 1
 Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
